Treatment of childhood acute myelogenous leukemia with an intensive regimen (AML-87) that individualizes etoposide and cytarabine dosages: short- and long-term effects-Reference-Cited by-同舟云学术

Treatment of childhood acute myelogenous leukemia with an intensive regimen (AML-87) that individualizes etoposide and cytarabine dosages: short- and long-term effects

Published:2000-10 Issue:10 Volume:14 Page:1736-1742
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Arnaout MK,Radomski KM,Srivastava DK,Tong X,Belt JR,Raimondi SC,Behm FG,Santana VM,Crom WR,Mirro J,Ribeiro RC

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/2401906.pdf

Reference33 articles.

1. Pui CH . Acute leukemia in children Curr Opin Hematol 1996 3: 249–258

2. Woods WG, Kobrinsky N, Buckley JD, Lee JW, Sanders J, Neudorf S, Gold S, Barnard DR, DeSwarte J, Dusenbery K, Kalousek D, Arthur DC, Lange BJ . Timed-sequential induction therapy improves postremission outcome in acute myeloid leukemia: a report from the Children's Cancer Group Blood 1996 87: 4979–4989

3. Stevens RF, Hann IM, Wheatley K, Gray RG . Marked improvements in outcome with chemotherapy alone in paediatric acute myeloid leukaemia: results of the United Kingdom Medical Research Council's 10th AML trial. MRC Childhood Leukaemia Working Party Br J Haematol 1998 101: 130–140

4. Mayer RJ, Davis RB, Schiffer CA, Berg DT, Powell BL, Schulman P, Omura GA, Moore JO, McIntyre OR, Frei E III . Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B New Engl J Med 1994 331: 896–903

5. Rees JK, Gray RG, Wheatley K . Dose intensification in acute myeloid leukaemia: greater effectiveness at lower cost. Principal report of the Medical Research Council's AML9 study. MRC Leukaemia in Adults Working Party Br J Haematol 1996 94: 89–98

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of NcRNAs to Regulate Immune Checkpoints in Cancer;Frontiers in Immunology;2022-04-06

2. Dose and therapy individualization in cancer chemotherapy;Handbook of Analytical Separations;2020

3. Hearing Status in Survivors of Childhood Acute Myeloid Leukemia Treated With Chemotherapy Only: A NOPHO-AML Study;Journal of Pediatric Hematology/Oncology;2019-01

4. POST: A framework for set-based association analysis in high-dimensional data;Methods;2018-08

5. The miR-125a-3p Inhibits TIM-3 Expression in AML Cell Line HL-60 In Vitro;Indian Journal of Hematology and Blood Transfusion;2016-10-06